Failure by a sponsor, either within the two-month period preceding the clinical trial or when a substantial amendment to the trial is made, to send the Agency the information required by law relating to the testing of medicinal products is punishable by two years’ imprisonment and a fine of 30,000 euros.
The same penalties will apply if a sponsor fails to comply with the Agency’s decision to oppose the implementation or modification of the trial.